Skip to main content

Advertisement

SpringerLink
Log in

Regulating microbiome manipulation

  • Comment
  • Published:

From Nature Medicine

View current issue Submit your manuscript

A crucial consideration for the clinical application of any burgeoning science is when the understanding of that field can be implemented without the risk of unforeseen harm. In our opinion, the need for caution is particularly urgent with respect to increasingly prevalent applications of microbiome science to medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Carlucci, C., Petrof, E. O. & Allen-Vercoe, E. EBioMedicine 13, 37–45 (2016).

    Article  Google Scholar 

  2. van Nood, E. et al. N. Engl. J. Med. 368, 407–415 (2013).

    Article  Google Scholar 

  3. Gupta, A., Cifu, A. S. & Khanna, S. JAMA 320, 1031–1032 (2018).

    Article  Google Scholar 

  4. Hoffman, D. et al. Science 358, 1390–1391 (2017).

    Article  Google Scholar 

  5. Sachs, R. E. & Edelistein, C. A. J. Law Biosci. 6, 396–415 (2015).

    Article  Google Scholar 

  6. Woodworth, M. H. et al. New Bioeth. 23, 210–218 (2017).

    Article  Google Scholar 

  7. Woodworth, M. H. et al. J. Clin. Micro. 55, 1002–1010 (2017).

    Article  CAS  Google Scholar 

  8. Enforcement Policy Regarding Investigational New Drug Requirements for use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection not Responsive to Standard Therapies. Draft Guidance for Industry (US FDA, 2016).

  9. Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion: Draft Guidance for Industry (ed. Center for Biologics Evaluation and Research) (US FDA, 2016).

  10. Kristensen, N. B. et al. Genome Med. 8, 52 (2016).

    Article  Google Scholar 

  11. Thomas, S. et al. Cancer Res. 77, 1783–1812 (2017).

    Article  CAS  Google Scholar 

  12. Aagaard, K. FASEB J. 27, 1012–1022 (2012).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Obstetrics & Gynecology, Molecular & Human Genetics, and Cell & Molecular Biology, Baylor College of Medicine and Texas Children’s Hospital, Houston, TX, USA

    Kjersti Aagaard

  2. Department of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Elizabeth Hohmann

Authors
  1. Kjersti Aagaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth Hohmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kjersti Aagaard.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aagaard, K., Hohmann, E. Regulating microbiome manipulation. Nat Med 25, 874–876 (2019). https://doi.org/10.1038/s41591-019-0451-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-019-0451-1

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation